{
    "Trade/Device Name(s)": [
        "Apieron INSIGHT\u2122 eNO System"
    ],
    "Submitter Information": "Apieron, Inc.",
    "510(k) Number": "K083617",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073265"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "December 24, 2008",
    "Summary Letter Received Date": "December 29, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3080"
    ],
    "Regulation Name(s)": [
        "Breath nitric oxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "misc"
    ],
    "Analyte(s)": [
        "Exhaled Nitric Oxide (eNO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [
        "Multi-use disposable Sensor Cartridge"
    ],
    "Instrument(s)/Platform(s)": [
        "Apieron INSIGHT\u2122 eNO Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Optical biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement of exhaled nitric oxide"
    ],
    "Submission Type(s)": [
        "System",
        "Monitor",
        "Sensor Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Apieron INSIGHT\u2122 eNO System for quantitative measurement of exhaled nitric oxide in expired human breath as an adjunct marker of inflammation in asthma.",
    "Indications for Use Summary": "Quantitatively measures exhaled nitric oxide in expired human breath as a marker of inflammation in persons with asthma, used to evaluate response to anti-inflammatory therapy in children (8-17) and adults (18+), in a physician's office laboratory setting.",
    "fda_folder": "Toxicology"
}